SentiAR

About SentiAR

SentiAR is a company focused on developing holographic Augmented Reality (AR) technology to provide physicians with real-time, interactive, 360-degree views during interventional procedures, enhancing visualization and control for better patient outcomes.

Products & Services

CommandEP:A system that creates interactive 3D visuals using real-time data from catheters and 3D electroanatomic mapping systems to reflect the inner heart surface anatomy, allowing physicians to understand procedures better and maintain sterility with a visual interface.

Specialties

Augmented Reality (AR) Holographic Technology Interventional Procedure Visualization 3D Electroanatomic Mapping

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 8500000 MR: - FA: $8.5 million FAN: 8500000	D: 2023-04-11 FD: 2023-04-11	6 investors

Series B Latest

2023-04-11

$8.5M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

B

Berk Tas

Chief Executive Officer and President of SentiAR

J

Jennifer Avari Silva

CMO & Co-Founder

J

Jonathan Silva

CTO & Co-Founder

M

Michael Southworth

VP of Technology & Co-Founder

A

Alex Schreiner

VP of Quality & Regulatory Affairs

S

Sharif Razzaque

Director of R&D

View 3 more team members with Pro

Unlock Full Team Directory

Recent News

SentiAR Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised